I 

116TH CONGRESS 

2D SESSION H. R. 7674 

To require the Director of the Centers for Disease Control and Prevention 

to create a standardized method for State, Tribal, and local health 

departments to report to the Centers with respect to COVID–19, and 

for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

JULY 20, 2020 

Mr. BEYER (for himself, Ms. SEWELL of Alabama, Mr. GARCI ́A of Illinois, Mr. 

SERRANO, Ms. SCANLON, Mr. HORSFORD, Mr. CONNOLLY, Mr. PERLMUTTER, Mr. LIPINSKI, Mr. CISNEROS, Ms. DEAN, Mr. PASCRELL, Mr. 

SUOZZI, Mr. LANGEVIN, Ms. MCCOLLUM, Mrs. AXNE, Ms. PORTER, Mr. 

GARAMENDI, Mr. GRIJALVA, Mrs. WATSON COLEMAN, Ms. GABBARD, 

Mr. CA ́RDENAS, Mr. WELCH, Mrs. LAWRENCE, Mr. SABLAN, Ms. 

SHERRILL, Ms. SPANBERGER, Mr. GONZALEZ of Texas, and Mr. ENGEL) 

introduced the following bill; which was referred to the Committee on Energy and Commerce 

A BILL 

To require the Director of the Centers for Disease Control 

and Prevention to create a standardized method for 

State, Tribal, and local health departments to report 

to the Centers with respect to COVID–19, and for other 

purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


kjohnson on DSK79L0C42PROD with BILLS
2 

•HR 7674 IH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘COVID–19 Data 

3 Transparency Act’’. 

4 SEC. 2. STANDARDIZED METHOD FOR HEALTH DEPART5 MENT REPORTING. 

6 (a) IN GENERAL.—Not later than 30 days after the 

7 date of enactment of this Act, the Director of the Centers 

8 for Disease Control and Prevention shall create a stand9 ardized method for State, Tribal, and local health depart10 ments to report to the Centers with respect to COVID– 

11 19 the following: 

12 (1) Daily hospitalizations of patients in the re13 spective jurisdiction with a confirmed or presumed 

14 case of COVID–19. 

15 (2) Daily numbers of such patients in the inten16 sive care unit. 

17 (3) Daily numbers of such patients on ventila18 tors. 

19 (4) How long such patients have been in the 

20 hospital. 

21 (5) Daily numbers of diagnostic and serological 

22 tests administered for SARS–CoV–2 with respect to 

23 patients in the respective jurisdiction, disaggregated 

24 by— 

25 (A) the type of test; and 


kjohnson on DSK79L0C42PROD with BILLS
3 

•HR 7674 IH

1 (B) the testing positivity rate of each type 

2 of test. 

3 (6) The sensitivity and specificity of each such 

4 type of test. 

5 (7) Daily numbers and percentages of contacts 

6 traced with respect to patients in the respective ju7 risdiction. 

8 (8) The rate of transmission of SARS–CoV–2 

9 in the respective jurisdiction. 

10 (b) POSTING BY CDC.—The Director of the Centers 

11 for Disease Control and Prevention shall— 

12 (1) post the information described in para13 graphs (1) through (8) of subsection (a), to the ex14 tent such information is in the possession of the 

15 Centers, on the public website of the Centers, except 

16 that such posting shall exclude any individually iden17 tifiable information; and 

18 (2) to the extent feasible disaggregate such in19 formation by State, Tribal, and local jurisdiction. 

20 (c) UPDATES.—The Director of the Centers for Dis21 ease Control and Prevention— 

22 (1) shall, as appropriate, periodically update the 

23 method posted under subsection (a); and 


kjohnson on DSK79L0C42PROD with BILLS
4 

•HR 7674 IH

1 (2) may revise and expand the reporting cat2 egories listed in such subsection. 

Æ 


kjohnson on DSK79L0C42PROD with BILLS